| Pituitary adenylate cyclase activating polypeptide anti-mitogenic signaling in cerebral cortical progenitors is regulated by p57Kip2-dependent CDK2 activity. | |
| | |
MedLine Citation:
|
PMID: 11880488 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Generation of distinct cell types and numbers in developing cerebral cortex is subject to regulation by extracellular factors that positively or negatively control precursor proliferation. Although signals stimulating proliferation are well described, factors halting cell cycle progression are less well defined. At the molecular level, production and association of cyclins, cyclin-dependent kinases (CDKs), and CDK inhibitors (CKIs) regulate cycle progression. We now report that the endogenous peptide, pituitary adenylate cyclase activating polypeptide (PACAP), negatively regulates the cell cycle by inhibiting p57Kip2-dependent CDK2 activity in embryonic cortex. Protein levels of CDK2 and members of the CIP/KIP family of CKIs (p27Kip1, p57Kip2) were detected in developing rat cortex from embryonic day 13.5 through postnatal day 2. With advancing development, CDK2 protein levels decreased, whereas CKI expression increased, suggesting that stimulatory and inhibitory cycle proteins control cell cycle exit. Using a well defined, nonsynchronized, 8 hr precursor culture, PACAP decreased the fraction of cells crossing the G1/S boundary, inhibiting DNA synthesis by 35%. CDK2 kinase activity was inhibited 75% by PACAP, whereas kinase protein and its regulatory cyclin E subunit were unaffected. Moreover, decreased kinase activity was accompanied by a twofold increase in levels of p57Kip2 protein, but not p21Cip1 or p27Kip1, suggesting that p57Kip2 mediates PACAP anti-mitogenic effects. Indeed, immunoprecipitation of CDK2 complex revealed increased p57Kip2 association with the kinase and concomitant reduction in free inhibitor after PACAP exposure, suggesting that p57Kip2 interactions directly regulate CDK2 activity. These observations establish a mechanism whereby anti-mitogenic signals actively induce cell cycle withdrawal in developing cortex. |
| | |
Authors:
|
Rebecca G Carey; Baogang Li; Emanuel DiCicco-Bloom |
Related Documents
:
|
9693368 - Cyclin d3-associated kinase activity is regulated by p27kip1 in balb/c 3t3 cells. 12970168 - Distinct molecular pathways mediate progesterone-induced growth inhibition and focal ad... 12649208 - The tyrphostin ag1024 accelerates the degradation of phosphorylated forms of retinoblas... 16103198 - The severe acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylate... 9092528 - Regulation of large calcium-activated potassium channels by protein phosphatase 2a. 19509078 - Eif2alpha kinases gcn2 and perk modulate transcription and translation of distinct sets... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: The Journal of neuroscience : the official journal of the Society for Neuroscience Volume: 22 ISSN: 1529-2401 ISO Abbreviation: J. Neurosci. Publication Date: 2002 Mar |
Date Detail:
|
Created Date: 2002-03-06 Completed Date: 2002-03-22 Revised Date: 2012-06-25 |
Medline Journal Info:
|
Nlm Unique ID: 8102140 Medline TA: J Neurosci Country: United States |
Other Details:
|
Languages: eng Pagination: 1583-91 Citation Subset: IM |
Affiliation:
|
Department of Neuroscience and Cell Biology, Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals CDC2-CDC28 Kinases* Cell Cycle / drug effects, physiology Cell Cycle Proteins / biosynthesis, metabolism Cell Lineage / drug effects Cells, Cultured Cerebral Cortex / cytology, embryology, metabolism Cyclin E / metabolism Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinase Inhibitor p57 Cyclin-Dependent Kinases / metabolism* DNA / biosynthesis Embryonic and Fetal Development / physiology HeLa Cells Humans Immunoblotting Macromolecular Substances Mitosis / drug effects, physiology Neuropeptides / metabolism*, pharmacology Nuclear Proteins / metabolism* Pituitary Adenylate Cyclase-Activating Polypeptide Protein-Serine-Threonine Kinases / metabolism* Rats Rats, Sprague-Dawley Signal Transduction / drug effects, physiology* Stem Cells / cytology, drug effects, metabolism* Tumor Suppressor Proteins / metabolism |
| Grant Support | |
ID/Acronym/Agency:
|
NS32401/NS/NINDS NIH HHS; T32 MH/AG 19957/MH/NIMH NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/ADCYAP1 protein, human; 0/Adcyap1 protein, rat; 0/CDKN1C protein, human; 0/Cdkn1b protein, rat; 0/Cell Cycle Proteins; 0/Cyclin E; 0/Cyclin-Dependent Kinase Inhibitor p57; 0/Macromolecular Substances; 0/Neuropeptides; 0/Nuclear Proteins; 0/Pituitary Adenylate Cyclase-Activating Polypeptide; 0/Tumor Suppressor Proteins; 147604-94-2/Cyclin-Dependent Kinase Inhibitor p27; 9007-49-2/DNA; EC 2.7.11.1/Protein-Serine-Threonine Kinases; EC 2.7.11.22/CDC2-CDC28 Kinases; EC 2.7.11.22/CDK2 protein, human; EC 2.7.11.22/Cdk2 protein, rat; EC 2.7.11.22/Cyclin-Dependent Kinase 2; EC 2.7.11.22/Cyclin-Dependent Kinases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Alternative splicing of the beta 4 subunit has alpha1 subunit subtype-specific effects on Ca2+ chann...
Next Document: Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's diseas...